{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:19:35Z","timestamp":1783685975154,"version":"3.55.0"},"reference-count":37,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/ylje5332","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:18:36Z","timestamp":1732853916000},"page":"6384-6398","source":"Crossref","is-referenced-by-count":3,"title":["PRKD3 promotes proliferation of liver cancer cells: a downstream proteomics profiling study"],"prefix":"10.62347","volume":"16","author":[{"given":"Ye","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1074\/jbc.M113.502633","article-title":"Elevated protein kinase D3 (PKD3) expression supports proliferation of triple-negative breast cancer cells and contributes to mTORC1-S6K1 pathway activation","volume":"289","author":"Huck","year":"2014","unstructured":"Huck B, Duss S, Hausser A and Olayioye MA. Elevated protein kinase D3 (PKD3) expression supports proliferation of triple-negative breast cancer cells and contributes to mTORC1-S6K1 pathway activation. J Biol Chem 2014; 289: 3138-3147.","journal-title":"J Biol Chem"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/cam4.1938","article-title":"Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer","volume":"8","author":"Liu","year":"2019","unstructured":"Liu Y, Li J, Ma Z, Zhang J, Wang Y, Yu Z, Lin X, Xu Z, Su Q, An L, Zhou Y, Ma X, Yang Y, Wang F, Chen Q, Zhang Y, Wang J, Zheng H, Shi A, Yu S, Zhang J, Zhao W and Chen L. Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer. Cancer Med 2019; 8: 729-741.","journal-title":"Cancer Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1002\/ijc.32798","article-title":"The GEF-H1\/PKD3 signaling pathway promotes the maintenance of triple-negative breast cancer stem cells","volume":"146","author":"Lieb","year":"2020","unstructured":"Lieb WS, Lungu C, Tamas R, Berreth H, Rathert P, Storz P, Olayioye MA and Hausser A. The GEF-H1\/PKD3 signaling pathway promotes the maintenance of triple-negative breast cancer stem cells. Int J Cancer 2020; 146: 3423-3434.","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"D&#xF6;ppler H, Bastea LI, Borges S, Spratley SJ, Pearce SE and Storz P. Protein kinase d isoforms differentially modulate cofilin-driven directed cell migration. PLoS One 2014; 9: e98090.","DOI":"10.1371\/journal.pone.0098090"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1158\/0008-5472.CAN-07-5156","article-title":"Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon\/PKD3 pathway downstream of Akt and ERK 1\/2","volume":"68","author":"Chen","year":"2008","unstructured":"Chen J, Deng F, Singh SV and Wang QJ. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon\/PKD3 pathway downstream of Akt and ERK 1\/2. Cancer Res 2008; 68: 3844-3853.","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.7150\/jca.31254","article-title":"Interplay of PKD3 with SREBP1 promotes cell growth via upregulating lipogenesis in prostate cancer cells","volume":"10","author":"Li","year":"2019","unstructured":"Li L, Hua L, Fan H, He Y, Xu W, Zhang L, Yang J, Deng F and Zeng F. Interplay of PKD3 with SREBP1 promotes cell growth via upregulating lipogenesis in prostate cancer cells. J Cancer 2019; 10: 6395-6404.","journal-title":"J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/1535-7163.MCT-11-0887","article-title":"Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer","volume":"11","author":"LaValle","year":"2012","unstructured":"LaValle CR, Zhang L, Xu S, Eiseman JL and Wang QJ. Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer. Mol Cancer Ther 2012; 11: 1389-1399.","journal-title":"Mol Cancer Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.yexcr.2019.04.022","article-title":"Protein kinase D3 promotes gastric cancer development through p65\/6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3 activation of glycolysis","volume":"380","author":"Zhang","year":"2019","unstructured":"Zhang J, Zhang Y, Wang J, Zhang S, Zhao Y, Ren H, Chu Y, Feng L and Wang C. Protein kinase D3 promotes gastric cancer development through p65\/6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3 activation of glycolysis. Exp Cell Res 2019; 380: 188-197.","journal-title":"Exp Cell Res"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"He JH, Li BX, Han ZP, Zou MX, Wang L, Lv YB, Zhou JB, Cao MR, Li YG and Zhang JZ. Snail-activated long non-coding RNA PCA3 up-regulates PRKD3 expression by miR-1261 sponging, thereby promotes invasion and migration of prostate cancer cells. Tumour Biol 2016; [Epub ahead of print].","DOI":"10.1007\/s13277-016-5450-y"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Zou Z, Zeng F, Xu W, Wang C, Ke Z, Wang QJ and Deng F. PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-&#x3BA;B- and HDAC1-mediated expression and activation of uPA. J Cell Sci 2012; 125: 4800-4811.","DOI":"10.1242\/jcs.106542"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.clinre.2017.02.005","article-title":"Higher PKD3 expression in hepatocellular carcinoma (HCC) tissues predicts poorer prognosis for HCC patients","volume":"41","author":"Yang","year":"2017","unstructured":"Yang H, Xu M, Chi X, Yan Q, Wang Y, Xu W, Zhuang K, Li A and Liu S. Higher PKD3 expression in hepatocellular carcinoma (HCC) tissues predicts poorer prognosis for HCC patients. Clin Res Hepatol Gastroenterol 2017; 41: 554-563.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"40298","DOI":"10.1074\/jbc.M106512200","article-title":"Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells","volume":"276","author":"Zhukova","year":"2001","unstructured":"Zhukova E, Sinnett-Smith J and Rozengurt E. Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells. J Biol Chem 2001; 276: 40298-40305.","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.0.CO;2-D","article-title":"Protein-kinase-Cmu expression correlates with enhanced keratinocyte proliferation in normal and neoplastic mouse epidermis and in cell culture","volume":"80","author":"Rennecke","year":"1999","unstructured":"Rennecke J, Rehberger PA, F&#xFC;rstenberger G, Johannes FJ, St&#xF6;hr M, Marks F and Richter KH. Protein-kinase-Cmu expression correlates with enhanced keratinocyte proliferation in normal and neoplastic mouse epidermis and in cell culture. Int J Cancer 1999; 80: 98-103.","journal-title":"Int J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1091\/mbc.e12-03-0198","article-title":"PKD controls mitotic Golgi complex fragmentation through a Raf-MEK1 pathway","volume":"24","author":"Kienzle","year":"2013","unstructured":"Kienzle C, Eisler SA, Villeneuve J, Brummer T, Olayioye MA and Hausser A. PKD controls mitotic Golgi complex fragmentation through a Raf-MEK1 pathway. Mol Biol Cell 2013; 24: 222-233.","journal-title":"Mol Biol Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature02650","article-title":"Cyclin-dependent kinases regulate the antiproliferative function of Smads","volume":"430","author":"Matsuura","year":"2004","unstructured":"Matsuura I, Denissova NG, Wang G, He D, Long J and Liu F. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 2004; 430: 226-231.","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1247\/csf.08019","article-title":"Migratory localization of cyclin D2-Cdk4 complex suggests a spatial regulation of the G1-S transition","volume":"33","author":"Wang","year":"2008","unstructured":"Wang Z, Xie Y, Zhang L, Zhang H, An X, Wang T and Meng A. Migratory localization of cyclin D2-Cdk4 complex suggests a spatial regulation of the G1-S transition. Cell Struct Funct 2008; 33: 171-183.","journal-title":"Cell Struct Funct"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1002\/j.1460-2075.1996.tb01097.x","article-title":"The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A\/E-Cdk2","volume":"15","author":"Kitagawa","year":"1996","unstructured":"Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Segawa K, Yoshida E, Nishimura S and Taya Y. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A\/E-Cdk2. EMBO J 1996; 15: 7060-7069.","journal-title":"EMBO J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1158\/1078-0432.CCR-13-0259","article-title":"The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma","volume":"19","author":"Sheppard","year":"2013","unstructured":"Sheppard KE and McArthur GA. The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma. Clin Cancer Res 2013; 19: 5320-5328.","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ccr.2010.08.012","article-title":"Nuclear cyclin D1\/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase","volume":"18","author":"Aggarwal","year":"2010","unstructured":"Aggarwal P, Vaites LP, Kim JK, Mellert H, Gurung B, Nakagawa H, Herlyn M, Hua X, Rustgi AK, McMahon SB and Diehl JA. Nuclear cyclin D1\/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. Cancer Cell 2010; 18: 329-340.","journal-title":"Cancer Cell"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/2159-8290.CD-14-0625","article-title":"PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers","volume":"5","author":"Li","year":"2015","unstructured":"Li Y, Chitnis N, Nakagawa H, Kita Y, Natsugoe S, Yang Y, Li Z, Wasik M, Klein-Szanto AJ, Rustgi AK and Diehl JA. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers. Cancer Discov 2015; 5: 288-303.","journal-title":"Cancer Discov"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.thromres.2012.06.023","article-title":"The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo","volume":"130","author":"De Craen B","year":"2012","unstructured":"Van De Craen B, Declerck PJ and Gils A. The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo. Thromb Res 2012; 130: 576-585.","journal-title":"Thromb Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/ATVBAHA.117.309451","article-title":"Plasminogen activator inhibitor-1 is a marker and a mediator of senescence","volume":"37","author":"Vaughan","year":"2017","unstructured":"Vaughan DE, Rai R, Khan SS, Eren M and Ghosh AK. Plasminogen activator inhibitor-1 is a marker and a mediator of senescence. Arterioscler Thromb Vasc Biol 2017; 37: 1446-1452.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1350426","DOI":"10.3389\/fonc.2024.1350426","article-title":"Analyses of hypoxia-related risk factors and clinical relevance in breast cancer","volume":"14","author":"Li","year":"2024","unstructured":"Li Y, Yu H, Han X and Pan Y. Analyses of hypoxia-related risk factors and clinical relevance in breast cancer. Front Oncol 2024; 14: 1350426.","journal-title":"Front Oncol"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Huang X, Wang L, Guo H and Zhang W. Single-cell RNA sequencing reveals SERPINE1-expressing CAFs remodelling tumour microenvironment in recurrent osteosarcoma. Clin Transl Med 2024; 14: e1527.","DOI":"10.1002\/ctm2.1527"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccr.2008.08.012","article-title":"Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis","volume":"14","author":"Bajou","year":"2008","unstructured":"Bajou K, Peng H, Laug WE, Maillard C, Noel A, Foidart JM, Martial JA and DeClerck YA. Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. Cancer Cell 2008; 14: 324-334.","journal-title":"Cancer Cell"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1055\/s-0038-1675399","article-title":"The urokinase plasminogen activator system in human cancers: an overview of its prognostic and predictive role","volume":"118","author":"Maduni&#x107","year":"2018","unstructured":"Maduni&#x107; J. The urokinase plasminogen activator system in human cancers: an overview of its prognostic and predictive role. Thromb Haemost 2018; 118: 2020-2036.","journal-title":"Thromb Haemost"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1345734","DOI":"10.3389\/fimmu.2023.1345734","article-title":"Metabolomics-transcriptomics joint analysis: unveiling the dysregulated cell death network and developing a diagnostic model for high-grade neuroblastoma","volume":"14","author":"Zhang","year":"2024","unstructured":"Zhang W, Zhang M, Sun M, Hu M, Yu M, Sun J, Zhang X and Du B. Metabolomics-transcriptomics joint analysis: unveiling the dysregulated cell death network and developing a diagnostic model for high-grade neuroblastoma. Front Immunol 2024; 14: 1345734.","journal-title":"Front Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1158\/1541-7786.MCR-13-0543","article-title":"PAI-1 leads to G1-phase cell-cycle progression through cyclin D3\/cdk4\/6 upregulation","volume":"12","author":"Giacoia","year":"2014","unstructured":"Giacoia EG, Miyake M, Lawton A, Goodison S and Rosser CJ. PAI-1 leads to G1-phase cell-cycle progression through cyclin D3\/cdk4\/6 upregulation. Mol Cancer Res 2014; 12: 322-334.","journal-title":"Mol Cancer Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"638701","DOI":"10.3389\/fonc.2021.638701","article-title":"SQSTM1\/p62 promotes cell growth and triggers autophagy in papillary thyroid cancer by regulating the AKT\/AMPK\/mTOR signaling pathway","volume":"11","author":"Yu","year":"2021","unstructured":"Yu F, Ma R, Liu C, Zhang L, Feng K, Wang M and Yin D. SQSTM1\/p62 promotes cell growth and triggers autophagy in papillary thyroid cancer by regulating the AKT\/AMPK\/mTOR signaling pathway. Front Oncol 2021; 11: 638701.","journal-title":"Front Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"14786","DOI":"10.1074\/jbc.M117.786160","article-title":"Adaptor protein p62 promotes skin tumor growth and metastasis and is induced by UVA radiation","volume":"292","author":"Sample","year":"2017","unstructured":"Sample A, Zhao B, Qiang L and He YY. Adaptor protein p62 promotes skin tumor growth and metastasis and is induced by UVA radiation. J Biol Chem 2017; 292: 14786-14795.","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ccell.2016.04.006","article-title":"p62, Upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells","volume":"29","author":"Umemura","year":"2016","unstructured":"Umemura A, He F, Taniguchi K, Nakagawa H, Yamachika S, Font-Burgada J, Zhong Z, Subramaniam S, Raghunandan S, Duran A, Linares JF, Reina-Campos M, Umemura S, Valasek MA, Seki E, Yamaguchi K, Koike K, Itoh Y, Diaz-Meco MT, Moscat J and Karin M. p62, Upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells. Cancer Cell 2016; 29: 935-948.","journal-title":"Cancer Cell"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"12030","DOI":"10.1038\/ncomms12030","article-title":"p62\/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming","volume":"7","author":"Saito","year":"2016","unstructured":"Saito T, Ichimura Y, Taguchi K, Suzuki T, Mizushima T, Takagi K, Hirose Y, Nagahashi M, Iso T, Fukutomi T, Ohishi M, Endo K, Uemura T, Nishito Y, Okuda S, Obata M, Kouno T, Imamura R, Tada Y, Obata R, Yasuda D, Takahashi K, Fujimura T, Pi J, Lee MS, Ueno T, Ohe T, Mashino T, Wakai T, Kojima H, Okabe T, Nagano T, Motohashi H, Waguri S, Soga T, Yamamoto M, Tanaka K and Komatsu M. p62\/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming. Nat Commun 2016; 7: 12030.","journal-title":"Nat Commun"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"22250","DOI":"10.1074\/jbc.M115.669242","article-title":"Small GTPase Rab2B and its specific binding protein golgi-associated Rab2B interactor-like 4 (GARI-L4) regulate golgi morphology","volume":"290","author":"Aizawa","year":"2015","unstructured":"Aizawa M and Fukuda M. Small GTPase Rab2B and its specific binding protein golgi-associated Rab2B interactor-like 4 (GARI-L4) regulate golgi morphology. J Biol Chem 2015; 290: 22250-22261.","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2015.08.016","article-title":"The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN\/NDP52 recruitment and TBK1 activation to promote mitophagy","volume":"60","author":"Heo","year":"2015","unstructured":"Heo JM, Ordureau A, Paulo JA, Rinehart J and Harper JW. The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN\/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol Cell 2015; 60: 7-20.","journal-title":"Mol Cell"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nn.4000","article-title":"Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia","volume":"18","author":"Freischmidt","year":"2015","unstructured":"Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, M&#xFC;ller K, Marroquin N, Nordin F, H&#xFC;bers A, Weydt P, Pinto S, Press R, Millecamps S, Molko N, Bernard E, Desnuelle C, Soriani MH, Dorst J, Graf E, Nordstr&#xF6;m U, Feiler MS, Putz S, Boeckers TM, Meyer T, Winkler AS, Winkelman J, de Carvalho M, Thal DR, Otto M, Br&#xE4;nnstr&#xF6;m T, Volk AE, Kursula P, Danzer KM, Lichtner P, Dikic I, Meitinger T, Ludolph AC, Strom TM, Andersen PM and Weishaupt JH. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 2015; 18: 631-636.","journal-title":"Nat Neurosci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"104471","DOI":"10.1016\/j.isci.2022.104471","article-title":"NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process","volume":"25","author":"Shen","year":"2022","unstructured":"Shen W, Luo P, Sun Y, Zhang W, Zhou N, Zhan H, Zhang Q, Shen J, Lin A, Cheng Q, Wang Q, Zhang J, Wang HH and Wei T. NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process. iScience 2022; 25: 104471.","journal-title":"iScience"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1080\/15548627.2020.1741332","article-title":"PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation","volume":"17","author":"MY","year":"2021","unstructured":"Wu MY, Liu L, Wang EJ, Xiao HT, Cai CZ, Wang J, Su H, Wang Y, Tan J, Zhang Z, Wang J, Yao M, Ouyang DF, Yue Z, Li M, Chen Y, Bian ZX and Lu JH. PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation. Autophagy 2021; 17: 1096-1111.","journal-title":"Autophagy"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/11\/ajtr0158884.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:54Z","timestamp":1766023014000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/11\/ajtr0158884.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/ylje5332","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}